Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Stanford University Dr. Anne Brunet New Faculty I Molecular mechanisms involved in adult neural stem cell maintenance $2,348,435
University of California, Merced Dr Jennifer O Manilay New Faculty I Enhancing Survival of Embryonic Stem Cell-Derived Grafts by Induction of Immunological Tolerance $1,576,389
University of California, Irvine Dr. Andrew Putnam New Faculty I A Novel Engineered Niche to Explore the Vasculogenic Potential of Embryonic Stem Cells $395,764
Stanford University Dr. Joanna Wysocka PhD New Faculty I Trithorax and Polycomb methyltransferase complexes in cell fate determination. $2,373,903
University of California, San Diego Dr. Kentson Lam New Faculty I Genetic dissection of mesodermal commitment to the hematopoietic fates. $2,150,620
University of Southern California Dr. Songtao Shi New Faculty I Oral and Craniofacial Reconstruction Using Mesenchymal Stem Cells $3,242,651
Scripps Research Institute Dr. Sheng Ding Dr. New Faculty I Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,393,876
Gladstone Institutes, J. David Sheng Ding PhD New Faculty I Reprogramming of human somatic cells back to pluripotent embryonic stem cells $1,320,101
Stanford University Karl Deisseroth New Faculty I Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny $2,424,209
Stanford University Dr. Howard Y. Chang New Faculty I Noncoding RNAs in Cell Fate Determination $2,985,894
BioTime, Inc. Dr. Michael D West Ph.D. Early Translational I Addressing the Cell Purity and Identity Bottleneck Through Generation and Expansion of Clonal Human Embryonic Progenitor Cell Lines $4,721,706
University of California, Davis Dr. Alice F Tarantal Early Translational I In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies $3,143,392
Salk Institute for Biological Studies Dr. Inder M. Verma Early Translational I Curing Hematological Diseases $5,979,252
Sanford Burnham Prebys Medical Discovery Institute Dr. Evan Y. Snyder Early Translational I Developmental Candidates for Cell-Based Therapies for Parkinson’s Disease (PD) $5,190,752
Stanford University Dr. Jill Helms Early Translational I Enhancing healing via Wnt-protein mediated activation of endogenous stem cells $6,464,126
Jackson Labs Pali G. Kaur Early Translational I Mouse Models for Stem Cell Therapeutic Development $3,759,134
Gladstone Institutes, J. David Dr. Warner C Greene Early Translational I Maximizing the Safety of Induced Pluripotent Stem Cells as an Infusion Therapy: Limiting the Mutagenic Threat of Retroelement Retrotransposition during iPSC Generation, Expansion and Differentiation $1,280,001
Scripps Research Institute Dr. Martin Friedlander Early Translational I Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration $5,806,321
University of California, Los Angeles Dr. Gabriel H. Travis Early Translational I Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration $5,487,136
Scripps Research Institute Dr. Jeanne F Loring Early Translational I Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation $5,830,771
ViaCyte, Inc. Dr. Olivia G. Kelly Early Translational I Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product $5,405,397
Scripps Health Dr. Darryl D. D’Lima Early Translational I Stem Cell-Based Therapy for Cartilage Regeneration and Osteoarthritis $3,118,431
University of California, Irvine Dr. Frank LaFerla Early Translational I Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease $3,599,997
University of California, Davis Dr Jan A Nolta Early Translational I Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,615,674
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 22 23 24 25 26 27 28 29 30 31 32

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More